Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma
Frontiers in Oncology · 19.06.2026 · 16
DOI: 10.3389/fonc.2026.1880587 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 19.06.2026. Verfasst von Hao Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, China. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Esophageal cancer is one of the most harmful upper gastrointestinal cancers, particularly in its advanced stages. Squamous cell carcinoma accounts for approximately 85% of all esophageal cancer cases among Chinese patients and is the main pathological type. Although first-line immunotherapy combined with chemotherapy has improved survival rates for stage IV esophageal squamous cell carcinoma (ESCC), some patients still experience suboptimal local control due to resistance to the treatment regimen. In patients with stage IV ESCC, disease progression at the primary site typically represents the main pattern of overall disease progression. Preclinical studies have clearly demonstrated a synergistic mechanism between radiotherapy and immunotherapy, and clinical evidence strongly suggests that the addition of consolidation radiotherapy can effectively enhance local lesion control and significantly prolong survival. Therefore, this review aims to explore the mechanisms of action of consolidation radiotherapy following first-line immunotherapy combined with chemotherapy in patients with stage IV ESCC, and to further analyze its feasibility and implementation strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Zitieren
APA
Su, H., Zhao, X., Qin, X., Zhou, X., Li, M., & Tian, L. (2026). Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1880587
Vancouver
Su H, Zhao X, Qin X, Zhou X, Li M, Tian L. Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1880587
BibTeX
@article{Su2026,
author = {Su, Hao and Zhao, Xinyu and Qin, Xiaoyu and Zhou, Xu and Li, Mianli and Tian, Lijun},
title = {Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1880587}
}
EUVIMED